Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Assessment of P2Y12 inhibitor usage and switching in acute coronary syndrome patients undergoing percutaneous coronary revascularization.

Autor: Kudaravalli M; Department of Medicine, Allegheny General Hospital, Pittsburgh, PA, United States., Althouse AD; Heart and Vascular Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Marroquin OC; Heart and Vascular Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Khandhar SJ; Division of Cardiology, University of Pennsylvania, Philadelphia, PA, United States., Sharbaugh MS; Heart and Vascular Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Toma C; Heart and Vascular Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Conrad Smith AJ; Heart and Vascular Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Schindler JT; Heart and Vascular Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Lee JS; Heart and Vascular Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Mulukutla SR; Heart and Vascular Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Division of Cardiology, Veterans Affairs Hospital, Pittsburgh, PA, United States. Electronic address: mulukutlasr@upmc.edu.

Publikováno v: International journal of cardiology [Int J Cardiol] 2016 Nov 15; Vol. 223, pp. 854-859. Date of Electronic Publication: 2016 Aug 08.